evidence_text: Rep. Longjohn moved to amend the bill as follows:
  
  1. Amend page 2, line 1, after “ apply ” by inserting a comma and “ or the brand name drug product or biological drug product is one found by the United States Food and Drug Administration to have a narrow therapeutic range ”.
  
  The motion did not prevail and the amendment was not adopted, a majority of the members serving not voting therefor.